275 related articles for article (PubMed ID: 2204661)
1. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group.
Marchesini G; Dioguardi FS; Bianchi GP; Zoli M; Bellati G; Roffi L; Martines D; Abbiati R
J Hepatol; 1990 Jul; 11(1):92-101. PubMed ID: 2204661
[TBL] [Abstract][Full Text] [Related]
2. [Branched-chain amino acids in the treatment of latent porto-systemic encephalopathy. A placebo-controlled double-blind cross-over study].
Egberts EH; Schomerus H; Hamster W; Jürgens P
Z Ernahrungswiss; 1986 Mar; 25(1):9-28. PubMed ID: 3524038
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of Hepatic-Aid and a Casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients.
McGhee A; Henderson JM; Millikan WJ; Bleier JC; Vogel R; Kassouny M; Rudman D
Ann Surg; 1983 Mar; 197(3):288-93. PubMed ID: 6830337
[TBL] [Abstract][Full Text] [Related]
4. Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study.
Egberts EH; Schomerus H; Hamster W; Jürgens P
Gastroenterology; 1985 Apr; 88(4):887-95. PubMed ID: 3882509
[TBL] [Abstract][Full Text] [Related]
5. Branched-chain amino acids in the treatment of chronic hepatic encephalopathy.
Eriksson LS; Persson A; Wahren J
Gut; 1982 Oct; 23(10):801-6. PubMed ID: 6749604
[TBL] [Abstract][Full Text] [Related]
6. Oral BCAA supplementation in cirrhosis with chronic encephalopathy: effects on prolactin and estradiol levels.
Bianchi GP; Marchesini G; Zoli M; Abbiati R; Ferrario E; Fabbri A; Pisi E
Hepatogastroenterology; 1992 Oct; 39(5):443-6. PubMed ID: 1459529
[TBL] [Abstract][Full Text] [Related]
7. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy.
Freund H; Dienstag J; Lehrich J; Yoshimura N; Bradford RR; Rosen H; Atamian S; Slemmer E; Holroyde J; Fischer JE
Ann Surg; 1982 Aug; 196(2):209-20. PubMed ID: 6284073
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study.
Plauth M; Egberts EH; Hamster W; Török M; Müller PH; Brand O; Fürst P; Dölle W
J Hepatol; 1993 Mar; 17(3):308-14. PubMed ID: 8315258
[TBL] [Abstract][Full Text] [Related]
9. Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver. A double blind crossover trial.
Sieg A; Walker S; Czygan P; Gärtner U; Lanzinger-Rossnagel G; Stiehl A; Kommerell B
Z Gastroenterol; 1983 Nov; 21(11):644-50. PubMed ID: 6362243
[TBL] [Abstract][Full Text] [Related]
10. Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis.
Vilstrup H; Gluud C; Hardt F; Kristensen M; Køhler O; Melgaard B; Dejgaard A; Hansen BA; Krintel JJ; Schütten HJ
J Hepatol; 1990 May; 10(3):291-6. PubMed ID: 2195106
[TBL] [Abstract][Full Text] [Related]
11. Branched chain amino acid therapy in liver disease.
Maddrey WC
J Am Coll Nutr; 1985; 4(6):639-50. PubMed ID: 3935706
[TBL] [Abstract][Full Text] [Related]
12. Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy.
Fabbri A; Magrini N; Bianchi G; Zoli M; Marchesini G
JPEN J Parenter Enteral Nutr; 1996; 20(2):159-64. PubMed ID: 8676537
[TBL] [Abstract][Full Text] [Related]
13. The use of ornithine salts of branched-chain ketoacids in portal-systemic encephalopathy.
Herlong HF; Maddrey WC; Walser M
Ann Intern Med; 1980 Oct; 93(4):545-50. PubMed ID: 7001971
[TBL] [Abstract][Full Text] [Related]
14. Enriched branched-chain amino acid formula versus a casein-based supplement in the treatment of cirrhosis.
Christie ML; Sack DM; Pomposelli J; Horst D
JPEN J Parenter Enteral Nutr; 1985; 9(6):671-8. PubMed ID: 3906162
[TBL] [Abstract][Full Text] [Related]
15. Branched-chain amino acids for people with hepatic encephalopathy.
Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
[TBL] [Abstract][Full Text] [Related]
16. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study.
Wahren J; Denis J; Desurmont P; Eriksson LS; Escoffier JM; Gauthier AP; Hagenfeldt L; Michel H; Opolon P; Paris JC; Veyrac M
Hepatology; 1983; 3(4):475-80. PubMed ID: 6345330
[TBL] [Abstract][Full Text] [Related]
17. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study.
Les I; Doval E; García-Martínez R; Planas M; Cárdenas G; Gómez P; Flavià M; Jacas C; Mínguez B; Vergara M; Soriano G; Vila C; Esteban R; Córdoba J
Am J Gastroenterol; 2011 Jun; 106(6):1081-8. PubMed ID: 21326220
[TBL] [Abstract][Full Text] [Related]
18. Oral keto analogs of branched-chain amino acids in hyperammonemia in patients with cirrhosis of the liver. A double-blind crossover study.
Walker S; Götz R; Czygan P; Stiehl A; Lanzinger G; Sieg A; Raedsch R; Kommerell B
Digestion; 1982; 24(2):105-11. PubMed ID: 7128954
[TBL] [Abstract][Full Text] [Related]
19. Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences.
Rossi Fanelli F; Cangiano C; Capocaccia L; Cascino A; Ceci F; Muscaritoli M; Giunchi G
Gut; 1986 Nov; 27 Suppl 1(Suppl 1):111-5. PubMed ID: 3539709
[TBL] [Abstract][Full Text] [Related]
20. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial.
Horst D; Grace ND; Conn HO; Schiff E; Schenker S; Viteri A; Law D; Atterbury CE
Hepatology; 1984; 4(2):279-87. PubMed ID: 6706302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
